Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment - Wikidata - wikimedia - TriplyDB

Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment

Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment

http://www.wikidata.org/entity/Q34482160

about

Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis The effects of epinephrine infusion in patients with von Willebrand's disease.Factor VIII-East Hartford (arginine 1689 to cysteine) has procoagulant activity when separated from von Willebrand factor.Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin The properties of immune complexes formed by human antibodies to factor VIII.Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein Pathogenesis, clinical picture and treatment of von Willebrand's disease.

P2860

Q33759739-1FD08024-E3F4-4592-BEC9-5F8BB92EB4F4 Q35202071-87237BA3-DB9D-4AC0-8F44-0CB51964C86E Q35601547-E02EA8FB-80D7-438C-9F36-847C6477B940 Q37047369-8FB5D278-169E-4694-B8C4-290236BFF960 Q37048262-FAF147D9-DFC4-4507-83EB-CFC8D04A18CE Q37319344-FC2C3C74-F67C-4FDB-85DC-262ACC52A76B Q40999861-D4BEBDEB-9103-4472-9649-A440B824EE44

P2860

Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment

http://www.wikidata.org/entity/Q34482160

description

1975 nî lūn-bûn

@nan

1975 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1975 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1975年の論文

@ja

1975年論文

@yue

1975年論文

@zh-hant

1975年論文

@zh-hk

1975年論文

@zh-mo

1975年論文

@zh-tw

1975年论文

@wuu

name

Effects of thrombin treatment ...... sociated small active fragment

@ast

Effects of thrombin treatment ...... sociated small active fragment

@en

Effects of thrombin treatment ...... sociated small active fragment

@nl

type

label

Effects of thrombin treatment ...... sociated small active fragment

@ast

Effects of thrombin treatment ...... sociated small active fragment

@en

Effects of thrombin treatment ...... sociated small active fragment

@nl

prefLabel

Effects of thrombin treatment ...... sociated small active fragment

@ast

Effects of thrombin treatment ...... sociated small active fragment

@en

Effects of thrombin treatment ...... sociated small active fragment

@nl

P1433

Q34482160-6782B46D-170C-4ED2-A7D7-2DB85A909571

P1476

Q34482160-7A1DDDD3-39D2-4010-BFD7-DCC3FECFE133

P2093

Q34482160-1381D1B3-E8D0-4DB0-9BF7-BA1A12368F18

Q34482160-177070FF-C003-496F-B566-F5573A59CE46

Q34482160-3989C76E-E421-442A-B31E-2185868C737A

Q34482160-68B58B35-C61C-4A12-B069-ED1E1BED943B

P2860

Q34482160-0B51DDDE-C7DB-46DD-B977-A6E49023CC36

Q34482160-0DD79153-B790-4668-90F1-904274570238

Q34482160-25076A25-B383-431C-92BD-56594D0E342B

Q34482160-32E3E8EF-65AD-497A-BA72-B6946472F272

Q34482160-36AC414E-4BD5-4243-878E-819B3A8B15DD

Q34482160-3E8D1662-AAFD-4BB2-81C4-157098C50EC9

Q34482160-441AD380-E955-4948-B7D1-FF0FE6708062

Q34482160-5674EF42-1BFE-453A-9915-23AE4FFBC0D5

Q34482160-5FDA7AC6-95C6-437E-AA71-31831DB6F3BE

Q34482160-6047A56A-21F9-40BF-8EBA-E2C1ACA5B97E

P304

Q34482160-455E11E2-CDBE-4175-95EE-1F6F7B95D7D9

P31

Q34482160-E5149C85-BC27-4898-9243-9F9D1F8807BE

P356

Q34482160-DA61FDA1-852A-42E4-83C0-A0FFFD98A61E

P407

Q34482160-80BBE1B2-076C-46EC-B294-FC7B8B2F904D

P433

Q34482160-CE433A6F-9FF8-4E0E-BBCF-C1B8475740E4

P478

Q34482160-AEFC10A1-D090-4D08-9857-FA8CEBF98103

P577

Q34482160-988FBEB6-4394-437C-8214-F71F56AA1633

P698

Q34482160-BA158A84-2B16-4540-AC9C-5B50D47164F8

P932

Q34482160-6DCD87A9-6729-4437-9160-9FCE43639DA3

P356

P1433

Journal of Clinical Investigation

P1476

Effects of thrombin treatment ...... sociated small active fragment

@en

P2093

Cooper HA

http://www.w3.org/2001/XMLSchema#string

Hall M

http://www.w3.org/2001/XMLSchema#string

Reisner FF

http://www.w3.org/2001/XMLSchema#string

Wagner RH

http://www.w3.org/2001/XMLSchema#string

P2860

The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis

Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

The kaolin clotting time; a rapid one-stage method for diagnosis of coagulation defects.

The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.

Factor VIII recombination after dissociation by CaCl12.

The subunit structure of normal and hemophilic factor VIII

Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.

Factor VIII (AHF) activity of small size produced by succinylating plasma.

Expression and linkage of genes for X-linked hemophilias A and B in the dog.

Isolation and characterization of human Factor VIII (antihemophilic factor).

P304

751-760

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI108146

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

1975-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1080490

http://www.w3.org/2001/XMLSchema#string

P932

301924

http://www.w3.org/2001/XMLSchema#string